In the published article, there was an error. The claim made by a referenced citation may not be supported by the literature.
A correction has been made to Feminizing hormone regimes, Paragraph 9.
This sentence previously stated: “Treatment will also reduce sperm quantity and quality, and eventually lead to irreversible infertility; this will occur even if hormonal therapy is halted (7)”.
The corrected sentence appears below: “Treatment will also reduce sperm quantity and quality, and eventually lead to irreversible infertility; this may occur even if hormonal therapy is halted”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: transgender, gender dysphoria, pharmacogenetics, hormonal therapy, estradiol, testosterone, spironolactone, pharmacodynamics
Citation: Sehgal I (2025) Corrigendum: Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations. Front. Endocrinol. 15:1537014. doi: 10.3389/fendo.2024.1537014
Received: 29 November 2024; Accepted: 13 December 2024;
Published: 06 January 2025.
Copyright © 2025 Sehgal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Inder Sehgal, SVNlaGdhbEBSVlUuZWR1
留言 (0)